Paraneoplastic, Autoantibody Profile
Also known as: Autoimmune Paraneoplastic Panel, Paraneoplastic, Paraneoplastic Syndrome Test
Use
This test is used for the detection of antineuronal autoantibodies that help in the diagnosis of paraneoplastic syndromes.
Special Instructions
Not provided.
Limitations
Negative results do not exclude all clinically relevant antibodies. If indicated, consider a phenotype-specific profile such as for encephalopathy, dementia, myelopathy, or axonal neuropathy. The test was developed according to CLIA requirements and not cleared or approved by the FDA.
Methodology
Immunoassay
Biomarkers
Anti-Hu Ab
ProteinCASPR2
ProteinCRMP-5 IgG
Protein
LOINC Codes
- 43104-9 - Paraneoplastic Ab Pnl Ser
- 84926-5 - PCA-Tr Ab Ser Ql IF
- 33422-7 - Amphiphysin Ab Ser Ql
- 43103-1 - CV2 IgG Ser-aCnc
- 84927-3 - Glial nuc type 1 Ab Ser Ql IF
- 31024-3 - VGCC Ab Ser-sCnc
- 82979-6 - CASPR2 IgG SerPl Ql IF
- 82978-8 - LGI1 IgG SerPl Ql IF
- 56850-1 - Imp & review of lab results
- 49738-8 - Hu Ab Ser Ql IF
- 43187-4 - Hu2 Ab Ser Ql IF
- 43102-3 - Hu3 Ab Ser Ql
- 84924-0 - PCA-1 Ab Ser Ql IF
- 84925-7 - PCA-2 Ab Ser Ql IF
Result Turnaround Time
4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
1 mL
Container
Gel barrier tube, red-top tube, serum transfer tube
Storage Instructions
Room temperature
Causes for Rejection
Gross hemolysis; grossly lipemic; gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant